{"product_id":"tesamorelin-10mg","title":"Tesamorelin 10mg","description":"\u003ch3\u003eWith \u003cstrong\u003e\u003cem\u003eFREE\u003c\/em\u003e\u003c\/strong\u003e BAC Water\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eCOAs available upon request\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch2\u003e\u003cspan\u003eTesamorelin\u003c\/span\u003e\u003c\/h2\u003e\n\u003ch3\u003e\u003cspan\u003eOverview\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eTesamorelin is a synthetic analogue of Growth Hormone-Releasing Hormone (GHRH) developed to selectively stimulate the release of endogenous growth hormone through activation of GHRH receptors in the anterior pituitary. Engineered with structural modifications that improve stability while maintaining receptor specificity, Tesamorelin has become an important research peptide in studies involving endocrine regulation, metabolism, and body composition.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eUsed exclusively for laboratory and research applications, Tesamorelin continues to be investigated in experimental models examining growth hormone physiology, lipid metabolism, and cellular signalling pathways associated with metabolic function.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cspan\u003eResearch Applications\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003ePreclinical and experimental studies have investigated Tesamorelin across several key areas of scientific interest:\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cstrong\u003e\u003cspan\u003eGrowth Hormone Secretion\u003c\/span\u003e\u003c\/strong\u003e\u003cbr\u003e\u003cspan\u003eResearchers study Tesamorelin for its ability to stimulate pulsatile secretion of endogenous growth hormone, providing a valuable model for investigating GHRH receptor activation and endocrine regulation.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cstrong\u003e\u003cspan\u003eMetabolic Physiology\u003c\/span\u003e\u003c\/strong\u003e\u003cbr\u003e\u003cspan\u003eExperimental models have explored the peptide's influence on lipid metabolism, glucose homeostasis, and energy utilisation, making it an important research tool in metabolic biology.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cstrong\u003e\u003cspan\u003eBody Composition Research\u003c\/span\u003e\u003c\/strong\u003e\u003cbr\u003e\u003cspan\u003eLaboratory investigations continue to evaluate Tesamorelin in studies examining fat metabolism, lean tissue maintenance, and physiological processes associated with body composition.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cstrong\u003e\u003cspan\u003eEndocrine Signalling\u003c\/span\u003e\u003c\/strong\u003e\u003cbr\u003e\u003cspan\u003eTesamorelin allows researchers to investigate the relationship between growth hormone, insulin-like growth factor-1 (IGF-1), and downstream metabolic pathways involved in nutrient utilisation and tissue regulation.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eThese characteristics have established Tesamorelin as a valuable research compound for laboratories studying GHRH biology, endocrine signalling, and metabolic physiology.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cspan\u003eTechnical Specifications\u003c\/span\u003e\u003c\/h3\u003e\n\u003cul data-spread=\"false\"\u003e\n\u003cli\u003e\n\u003cstrong\u003e\u003cspan\u003eChemical Name:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Tesamorelin Acetate\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e\u003cspan\u003eAlternative Names:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e TH9507; Egrifta® (research reference)\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e\u003cspan\u003eMolecular Formula:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e C₂₂₁H₃₆₆N₇₂O₆₇S\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e\u003cspan\u003eMolecular Weight:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Approximately 5135.9 g\/mol\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e\u003cspan\u003eAmino Acid Sequence:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Ser-NH₂\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e\u003cspan\u003eCAS Number:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e 218949-48-5\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e\u003cspan\u003ePeptide Classification:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Synthetic Growth Hormone-Releasing Hormone (GHRH) analogue\u003c\/span\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003e\u003cspan\u003eStorage Recommendations\u003c\/span\u003e\u003c\/h3\u003e\n\u003cul data-spread=\"false\"\u003e\n\u003cli\u003e\u003cspan\u003eLyophilized Tesamorelin remains stable at room temperature during short-term handling.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\n\u003cspan\u003eFor long-term storage, keep the peptide at \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003e−20 °C or below\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e.\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cspan\u003eFollowing reconstitution, refrigerate between \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003e2 °C and 8 °C\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e. Stability after reconstitution will depend on the solvent used and storage conditions.\u003c\/span\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003e\u003cspan\u003eSolubility\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eTesamorelin is generally soluble in sterile water, bacteriostatic water, and compatible aqueous buffer solutions, depending on formulation and purity.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cspan\u003eReferences\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eThorner, M. O., Strasburger, C. J., Wu, Z., et al. (1996). \u003c\/span\u003e\u003cem\u003e\u003cspan\u003eGrowth hormone-releasing hormone analogue therapy and stimulation of endogenous growth hormone secretion.\u003c\/span\u003e\u003c\/em\u003e\u003cspan\u003e Journal of Clinical Endocrinology \u0026amp; Metabolism.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eFalutz, J., Allas, S., Blot, K., et al. (2007). \u003c\/span\u003e\u003cem\u003e\u003cspan\u003eMetabolic effects of a growth hormone-releasing factor analogue in HIV-infected patients with abdominal fat accumulation.\u003c\/span\u003e\u003c\/em\u003e\u003cspan\u003e New England Journal of Medicine, 357(23), 2359–2370.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eStanley, T. L., \u0026amp; Grinspoon, S. K. (2015). \u003c\/span\u003e\u003cem\u003e\u003cspan\u003eEffects of growth hormone-releasing hormone analogues on metabolism and body composition.\u003c\/span\u003e\u003c\/em\u003e\u003cspan\u003e Nature Reviews Endocrinology, 11(3), 183–194.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e\u003cem\u003e\u003cstrong\u003eResearch compound only. Not for human consumption\u003c\/strong\u003e\u003c\/em\u003e\u003c\/span\u003e\u003c\/p\u003e","brand":"My Store","offers":[{"title":"Default Title","offer_id":54735588163913,"sku":null,"price":55.6,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1019\/7493\/3833\/files\/Tesamorelin10mg.png?v=1782667904","url":"https:\/\/truformlabs.co.uk\/products\/tesamorelin-10mg","provider":"TruForm Labs","version":"1.0","type":"link"}